Physician profile
James Weinberg
NPI 1861886426
$9,649.38
in general payments reported to CMS, 2019-2025
15 companies · $876 in 2025
The $876 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $379 · 2022: $384 · 2023: $4,859 · 2024: $3,151 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,338 · Travel and Lodging: $1,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,338.33 |
| Travel and Lodging | $1,547.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,942.20 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic, INC. | $847.74 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $550.87 | 2023-2024 | Senza |
| Abbott Laboratories | $428.61 | 2022-2023 | Proclaim, Ionicrf |
| Spr Therapeutics, INC | $284.13 | 2023-2025 | Sprint Pns System |
| Merck Sharp & Dohme LLC | $150.58 | 2024-2025 | Bridion |
| Saluda Medical Americas, INC. | $118.42 | 2024-2025 | Evoke |
| Coastal Medical Technologies LLC | $79.03 | 2024 | |
| Merit Medical Systems INC | $55.20 | 2023 | Stabilit |
| Azurity Pharmaceuticals, INC. | $46.83 | 2024 | Horizant |
| Relievant Medsystems, INC. | $41.60 | 2023 | Intracept |
| Abbvie INC. | $36.13 | 2024 | |
| Stimwave Technologies Incorporated | $25.44 | 2021 | |
| Protega Pharmaceutials INC | $23.71 | 2025 | Roxybond |
| Vertos Medical, INC. | $18.89 | 2023 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Weinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.